Cargando…
_version_ 1785091110208536576
author Tan, Carlyn
Searle, Emma
Anguille, Sébastien
Bhutani, Manisha
Biran, Noa
Boyd, Kevin
Cowan, Andrew
Matous, Jeffrey
Perrot, Aurore
Berdeja, Jesus
Janowski, Wojciech
Popat, Rakesh
Quach, Hang
Schroeder, Mark
Wong, Sandy W
Vishwamitra, Deeksha
Guo, Yue
Niu, Zhuolu
Larsen, Julie
Chen, Lingling
Banerjee, Arnob
Touzeau, Cyrille
author_facet Tan, Carlyn
Searle, Emma
Anguille, Sébastien
Bhutani, Manisha
Biran, Noa
Boyd, Kevin
Cowan, Andrew
Matous, Jeffrey
Perrot, Aurore
Berdeja, Jesus
Janowski, Wojciech
Popat, Rakesh
Quach, Hang
Schroeder, Mark
Wong, Sandy W
Vishwamitra, Deeksha
Guo, Yue
Niu, Zhuolu
Larsen, Julie
Chen, Lingling
Banerjee, Arnob
Touzeau, Cyrille
author_sort Tan, Carlyn
collection PubMed
description
format Online
Article
Text
id pubmed-10431062
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104310622023-08-17 P865: TECLISTAMAB IN COMBINATION WITH LENALIDOMIDE IN PREVIOUSLY TREATED PATIENTS WITH MULTIPLE MYELOMA IN THE PHASE 1B MULTICOHORT MAJESTEC-2 STUDY Tan, Carlyn Searle, Emma Anguille, Sébastien Bhutani, Manisha Biran, Noa Boyd, Kevin Cowan, Andrew Matous, Jeffrey Perrot, Aurore Berdeja, Jesus Janowski, Wojciech Popat, Rakesh Quach, Hang Schroeder, Mark Wong, Sandy W Vishwamitra, Deeksha Guo, Yue Niu, Zhuolu Larsen, Julie Chen, Lingling Banerjee, Arnob Touzeau, Cyrille Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431062/ http://dx.doi.org/10.1097/01.HS9.0000970364.16259.0e Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Tan, Carlyn
Searle, Emma
Anguille, Sébastien
Bhutani, Manisha
Biran, Noa
Boyd, Kevin
Cowan, Andrew
Matous, Jeffrey
Perrot, Aurore
Berdeja, Jesus
Janowski, Wojciech
Popat, Rakesh
Quach, Hang
Schroeder, Mark
Wong, Sandy W
Vishwamitra, Deeksha
Guo, Yue
Niu, Zhuolu
Larsen, Julie
Chen, Lingling
Banerjee, Arnob
Touzeau, Cyrille
P865: TECLISTAMAB IN COMBINATION WITH LENALIDOMIDE IN PREVIOUSLY TREATED PATIENTS WITH MULTIPLE MYELOMA IN THE PHASE 1B MULTICOHORT MAJESTEC-2 STUDY
title P865: TECLISTAMAB IN COMBINATION WITH LENALIDOMIDE IN PREVIOUSLY TREATED PATIENTS WITH MULTIPLE MYELOMA IN THE PHASE 1B MULTICOHORT MAJESTEC-2 STUDY
title_full P865: TECLISTAMAB IN COMBINATION WITH LENALIDOMIDE IN PREVIOUSLY TREATED PATIENTS WITH MULTIPLE MYELOMA IN THE PHASE 1B MULTICOHORT MAJESTEC-2 STUDY
title_fullStr P865: TECLISTAMAB IN COMBINATION WITH LENALIDOMIDE IN PREVIOUSLY TREATED PATIENTS WITH MULTIPLE MYELOMA IN THE PHASE 1B MULTICOHORT MAJESTEC-2 STUDY
title_full_unstemmed P865: TECLISTAMAB IN COMBINATION WITH LENALIDOMIDE IN PREVIOUSLY TREATED PATIENTS WITH MULTIPLE MYELOMA IN THE PHASE 1B MULTICOHORT MAJESTEC-2 STUDY
title_short P865: TECLISTAMAB IN COMBINATION WITH LENALIDOMIDE IN PREVIOUSLY TREATED PATIENTS WITH MULTIPLE MYELOMA IN THE PHASE 1B MULTICOHORT MAJESTEC-2 STUDY
title_sort p865: teclistamab in combination with lenalidomide in previously treated patients with multiple myeloma in the phase 1b multicohort majestec-2 study
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431062/
http://dx.doi.org/10.1097/01.HS9.0000970364.16259.0e
work_keys_str_mv AT tancarlyn p865teclistamabincombinationwithlenalidomideinpreviouslytreatedpatientswithmultiplemyelomainthephase1bmulticohortmajestec2study
AT searleemma p865teclistamabincombinationwithlenalidomideinpreviouslytreatedpatientswithmultiplemyelomainthephase1bmulticohortmajestec2study
AT anguillesebastien p865teclistamabincombinationwithlenalidomideinpreviouslytreatedpatientswithmultiplemyelomainthephase1bmulticohortmajestec2study
AT bhutanimanisha p865teclistamabincombinationwithlenalidomideinpreviouslytreatedpatientswithmultiplemyelomainthephase1bmulticohortmajestec2study
AT birannoa p865teclistamabincombinationwithlenalidomideinpreviouslytreatedpatientswithmultiplemyelomainthephase1bmulticohortmajestec2study
AT boydkevin p865teclistamabincombinationwithlenalidomideinpreviouslytreatedpatientswithmultiplemyelomainthephase1bmulticohortmajestec2study
AT cowanandrew p865teclistamabincombinationwithlenalidomideinpreviouslytreatedpatientswithmultiplemyelomainthephase1bmulticohortmajestec2study
AT matousjeffrey p865teclistamabincombinationwithlenalidomideinpreviouslytreatedpatientswithmultiplemyelomainthephase1bmulticohortmajestec2study
AT perrotaurore p865teclistamabincombinationwithlenalidomideinpreviouslytreatedpatientswithmultiplemyelomainthephase1bmulticohortmajestec2study
AT berdejajesus p865teclistamabincombinationwithlenalidomideinpreviouslytreatedpatientswithmultiplemyelomainthephase1bmulticohortmajestec2study
AT janowskiwojciech p865teclistamabincombinationwithlenalidomideinpreviouslytreatedpatientswithmultiplemyelomainthephase1bmulticohortmajestec2study
AT popatrakesh p865teclistamabincombinationwithlenalidomideinpreviouslytreatedpatientswithmultiplemyelomainthephase1bmulticohortmajestec2study
AT quachhang p865teclistamabincombinationwithlenalidomideinpreviouslytreatedpatientswithmultiplemyelomainthephase1bmulticohortmajestec2study
AT schroedermark p865teclistamabincombinationwithlenalidomideinpreviouslytreatedpatientswithmultiplemyelomainthephase1bmulticohortmajestec2study
AT wongsandyw p865teclistamabincombinationwithlenalidomideinpreviouslytreatedpatientswithmultiplemyelomainthephase1bmulticohortmajestec2study
AT vishwamitradeeksha p865teclistamabincombinationwithlenalidomideinpreviouslytreatedpatientswithmultiplemyelomainthephase1bmulticohortmajestec2study
AT guoyue p865teclistamabincombinationwithlenalidomideinpreviouslytreatedpatientswithmultiplemyelomainthephase1bmulticohortmajestec2study
AT niuzhuolu p865teclistamabincombinationwithlenalidomideinpreviouslytreatedpatientswithmultiplemyelomainthephase1bmulticohortmajestec2study
AT larsenjulie p865teclistamabincombinationwithlenalidomideinpreviouslytreatedpatientswithmultiplemyelomainthephase1bmulticohortmajestec2study
AT chenlingling p865teclistamabincombinationwithlenalidomideinpreviouslytreatedpatientswithmultiplemyelomainthephase1bmulticohortmajestec2study
AT banerjeearnob p865teclistamabincombinationwithlenalidomideinpreviouslytreatedpatientswithmultiplemyelomainthephase1bmulticohortmajestec2study
AT touzeaucyrille p865teclistamabincombinationwithlenalidomideinpreviouslytreatedpatientswithmultiplemyelomainthephase1bmulticohortmajestec2study